Lie (Leo) Ma, PhD
About Lie (Leo) Ma, PhD
Lie (Leo) Ma, PhD, is the Vice President of Biotech Equity Research at Jefferies, with extensive experience in biotechnology and pharmaceutical research.
Current Role at Jefferies
Lie (Leo) Ma, PhD, serves as the Vice President of Biotech Equity Research at Jefferies. He joined the firm in 2021 and is based in New York, New York. In his current role, he is involved in analyzing and providing insights on the biotechnology sector for the firm's clients.
Previous Experience at Wolfe Research
Prior to his position at Jefferies, Lie (Leo) Ma worked at Wolfe Research, LLC. From 2018 to 2021, he held the role of Senior Equity Research Associate - Biotech & Spec Pharma. At Wolfe Research, he specialized in the biotechnology and specialty pharmaceutical sectors, providing valuable research and analysis.
Consulting and Internships
Leo Ma has amassed diverse experience through various consulting and internship roles. In 2016, he worked as a Consultant at Biorez in New Haven, Connecticut. Additionally, from 2016 to 2018, he served as a Technology Transfer Intern at Yale Office of Cooperative Research. He also gained editorial experience as the Deputy Editor of the Yale Journal of Biology and Medicine from 2015 to 2016. Earlier in his career, he interned at Bristol-Myers Squibb as a Summer Research Intern in 2013.
Education and Qualifications
Leo Ma's academic background is extensive and distinguished. He earned his PhD in Molecular Pharmacology from Yale University, where he studied from 2012 to 2018. Prior to that, he studied Bioengineering and Biomedical Engineering at the University of California, Berkeley, in 2011. He completed his undergraduate studies at Zhejiang University, where he obtained a Bachelor of Science (BS) in Biological Sciences from 2008 to 2012. He also holds a High School Diploma from Nanjing Foreign Language School, where he studied from 2002 to 2008.